Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 59 (3), 411-8

Long-term Efficacy of Soy-Based Meal Replacements vs an Individualized Diet Plan in Obese Type II DM Patients: Relative Effects on Weight Loss, Metabolic Parameters, and C-reactive Protein

Affiliations
Clinical Trial

Long-term Efficacy of Soy-Based Meal Replacements vs an Individualized Diet Plan in Obese Type II DM Patients: Relative Effects on Weight Loss, Metabolic Parameters, and C-reactive Protein

Z Li et al. Eur J Clin Nutr.

Abstract

Background: Achieving significant weight loss and glycemic control in diabetic patients remains a challenging task.

Objective: This study compared the effects of a soy-based meal replacement (MR) plan vs an individualized diet plan (IDP; as recommended by the American Diabetes Association) on weight loss and metabolic profile.

Design/subjects: A total of 104 subjects were randomized prospectively to the two treatments for a total of 12 months.

Results: In all, 77 of the 104 subjects completed the study. Percentage weight loss in MR group (4.57+/-0.81%) was significantly greater (P<0.05) than in IDP group (2.25+/-0.72%). Fasting plasma glucose was significantly reduced in MR group (126.4+/-4.9 mg/dl) compared with IDP group (152.5+/-6.6 mg/dl, P<0.0001) at 6 months but not at 12 months. Controlling for baseline levels, hemoglobin Alc level improved by 0.49+/-0.22% for those receiving MR when compared to IDP group (P<0.05). A greater number of subjects in MR group reduced their use of sulfonylureas (P<0.0001) and metformin (P<0.05) as compared to IDP group. High-sensitivity C-reactive protein (hs-CRP) decreased -26.3% (P = 0.019) in MR group compared to -7.06% (P = 0.338) in IDP group at 6 months. Similar changes were observed at 12 months with MR groups, with hs-CRP decreasing by -25.0% (P = 0.019) compared to -18.7% (P = 0.179) in IDP group.

Conclusion: This study demonstrates that MR is a viable strategy for weight reduction in diabetic patients, resulting in beneficial changes in measures of glycemic control and reduction of medications.

Similar articles

See all similar articles

Cited by 33 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback